Author： Dhillon Sohita Weber Juliane
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.69, Iss.15, 2009-10, pp. : 2103-2114
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Success for saxagliptin in South Africa
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 656, 2012-01 ,pp. :
Access to resources
Recommend
Costs of saxagliptin "acceptable" in Germany
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 648, 2012-01 ,pp. :
Metformin ++ saxagliptin for type 2 diabetes
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. :
Saxagliptin overview: special focus on safety and adverse effects
Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. :
Pharmacokinetic Study of Saxagliptin in Healthy Chinese Subjects
By Li Haiyan
Clinical Drug Investigation, Vol. 32, Iss. 7, 2012-07 ,pp. :